Emory University School of Medicine, Emory Heart and Vascular Center, Atlanta, GA, USA.
Am J Cardiol. 2013 Aug 15;112(4):S2. doi: 10.1016/j.amjcard.2013.06.002.
According to The National Coalition for Women's Health Research's 10Q Report: Advancing women's heart health through improved research, diagnosis, and treatment published in June 2011, cardiovascular disease (CVD), a term used to describe diseases of the heart or blood vessels, is the leading cause of death for women in the United States, causing more than 420,000 deaths among women annually. Experts estimate that one in two women will die of heart disease or stroke compared with one in 25 women who will die of breast cancer. Despite the fact that more women than men die each year of heart disease and that there are known sex differences in symptoms and treatment, medical treatment of women has not changed substantially nor has it resulted in appropriate research into the distinct sex differences that exist in CVD. Time is of the essence. CVD death rates are increasing for women under age 55, despite an overall decrease in death rates from CVD in recent years. This multimedia webcast will address the challenges of clinical practice with regard to the role of female gender in the diagnosis and treatment of cardiovascular disease and to help answer questions about the 10 topics of concern in the 10Q Report. A panel of experts presents emerging evidence-based data and exercise clinical decision making by incorporating clinical cases and panel discussions.
根据 2011 年 6 月发布的《全国妇女健康研究联盟的 10Q 报告：通过改进研究、诊断和治疗促进妇女心脏健康》，心血管疾病（CVD）是用来描述心脏或血管疾病的术语，是美国女性的主要死亡原因，每年导致超过 42 万名女性死亡。专家估计，每两名女性中就有一人会死于心脏病或中风，而死于乳腺癌的女性则为 1/25。尽管每年死于心脏病的女性多于男性，而且症状和治疗方面存在已知的性别差异，但女性的医疗治疗并没有发生重大变化，也没有针对 CVD 中存在的明显性别差异进行适当的研究。时间至关重要。尽管近年来 CVD 的死亡率总体有所下降，但 55 岁以下女性的 CVD 死亡率仍在上升。这个多媒体网络广播将讨论临床实践中面临的挑战，即女性性别在心血管疾病的诊断和治疗中的作用，并帮助回答 10Q 报告中 10 个关注主题的问题。一个专家小组通过结合临床病例和小组讨论，提出了新的循证数据和临床决策。
